Carmell Therapeutics Corporation Class A Common Stock Soared
Thu, Jul 27, 2023 at 07:37 PM
Carmell Therapeutics Corporation Class A Common Stock (CTCX:NASDAQ) rocketted at $4.38, a gain of 46%. The stock appeared on our News Catalysts scanner on Thu, Jul 27, 2023 at 07:40 AM in the 'MERGER' category. From Thu, Jul 13, 2023, the stock recorded 30.00% Up Days and 36.36% Green Days
About Carmell Therapeutics Corporation Class A Common Stock (CTCX:NASDAQ)
Alpha Healthcare Acquisition Corp III is a blank check company.
Top 10 Gainers:
- Statera Biopharma Inc. (STAB:NASDAQ), 616.67%
- Femasys Inc. (FEMY:NASDAQ), 130.77%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 105%
- UroGen Pharma Ltd. (URGN:NASDAQ), 98.56%
- Greenbrook TMS Inc. (GBNH:NASDAQ), 90.38%
- Tupperware Brands Corporation (TUP:NYSE), 56.32%
- Colombier Acquisition Corp. Class A (CLBR:NYSE), 54.51%
- Ultralife Corporation (ULBI:NASDAQ), 52.54%
- Carmell Therapeutics Corporation Class A Common Stock (CTCX:NASDAQ), 46%
- View Inc. (VIEW:NASDAQ), 44.36%